The Zhitong Finance App learned that according to media reports, French biotech company TheRavectys SA is considering an IPO in Hong Kong. According to people familiar with the matter, Theravectys is working with consultants to evaluate or raise hundreds of millions of dollars in IPO plans to be carried out as soon as this year. TheRavectys representatives have yet to respond.

The Zhitong Finance App learned that according to media reports, French biotech company TheRavectys SA is considering an IPO in Hong Kong. According to people familiar with the matter, Theravectys is working with consultants to evaluate or raise hundreds of millions of dollars in IPO plans to be carried out as soon as this year. TheRavectys representatives have yet to respond.